NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+20.68%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$925M
AUM Growth
+$925M
(+97%)
Cap. Flow
+$405M
Cap. Flow
% of AUM
43.79%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
212
New
35
Increased
67
Reduced
36
Closed
29
Top Buys
| 1 |
NovoCure
NVCR
|
$17.7M |
| 2 |
argenx
ARGX
|
$17.6M |
| 3 |
Twist Bioscience
TWST
|
$17.1M |
| 4 |
Teladoc Health
TDOC
|
$16.9M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$16.5M |
Top Sells
| 1 |
Dick's Sporting Goods
DKS
|
$6.73M |
| 2 |
Topgolf Callaway Brands
MODG
|
$6.28M |
| 3 |
Bank of America Series L
BAC.PRL
|
$5.37M |
| 4 |
Frontdoor
FTDR
|
$5.3M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
$4.05M |
Sector Composition
| 1 | Healthcare | 48.41% |
| 2 | Technology | 11.82% |
| 3 | Consumer Discretionary | 8.18% |
| 4 | Industrials | 6.85% |
| 5 | Communication Services | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $11.1M | 1.2% |
216,983
+169,872
| +361% | +$8.71M |
|
27
BridgeBio Pharma
BBIO
$9.91B
| $11M | 1.19% |
292,982
+239,626
| +449% | +$8.99M |
|
28
Insulet
PODD
$24.2B
| $10.6M | 1.14% |
44,738
+36,675
| +455% | +$8.68M |
|
29
Sarepta Therapeutics
SRPT
$1.98B
| $10.5M | 1.13% |
74,412
+61,844
| +492% | +$8.69M |
|
|
GBT
30
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.4M | 1.13% |
189,392
+152,293
| +411% | +$8.4M |
|
31
Penumbra
PEN
$10.5B
| $10.1M | 1.09% |
51,780
+44,212
| +584% | +$8.59M |
|
32
TFI International
TFII
$7.92B
| $9.76M | 1.06% |
233,382
+54,185
| +30% | +$2.27M |
|
33
Krystal Biotech
KRYS
$4.35B
| $9.58M | 1.04% |
222,422
+182,914
| +463% | +$7.87M |
|
|
AFIB
34
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $9.56M | 1.03% |
+320,627
| New | +$9.56M |
|
35
Esperion Therapeutics
ESPR
$490M
| $8.77M | 0.95% |
235,855
+202,240
| +602% | +$7.52M |
|
36
Elastic
ESTC
$9.17B
| $8.75M | 0.95% |
81,136
+1,995
| +3% | +$215K |
|
37
Innovative Industrial Properties
IIPR
$1.54B
| $8.72M | 0.94% |
70,221
+27,341
| +64% | +$3.39M |
|
|
38
Topgolf Callaway Brands
MODG
$1.69B
| $8.33M | 0.9% |
435,336
-327,998
| -43% | -$6.28M |
|
|
TRIL
39
DELISTED
Trillium Therapeutics Inc.
TRIL
| $8.15M | 0.88% |
+573,629
| New | +$8.15M |
|
40
Ameresco
AMRC
$1.35B
| $7.5M | 0.81% |
+224,545
| New | +$7.5M |
|
41
Chegg
CHGG
$173M
| $7.37M | 0.8% |
103,214
+3,369
| +3% | +$241K |
|
42
BioMarin Pharmaceuticals
BMRN
$11.3B
| $7.33M | 0.79% |
+96,276
| New | +$7.33M |
|
43
Trex
TREX
$6.41B
| $7.3M | 0.79% |
101,952
+52,179
| +105% | +$172K |
|
44
Anywhere Real Estate
HOUS
$670M
| $6.68M | 0.72% |
+707,244
| New | +$6.68M |
|
|
SAGE
45
DELISTED
Sage Therapeutics
SAGE
| $6.47M | 0.7% |
+105,771
| New | +$6.47M |
|
46
TG Therapeutics
TGTX
$5.03B
| $6.14M | 0.66% |
+229,452
| New | +$6.14M |
|
|
MDLA
47
DELISTED
Medallia, Inc.
MDLA
| $6.11M | 0.66% |
222,637
+21,384
| +11% | +$586K |
|
48
CACI
CACI
$10.3B
| $6.02M | 0.65% |
28,250
-5,678
| -17% | -$1.21M |
|
|
49
Bank of America Series L
BAC.PRL
$3.85B
| – | – |
0
| – | -$5.37M |
|
50
Palomar
PLMR
$3.3B
| $5.88M | 0.64% |
56,451
-6,694
| -11% | -$698K |
|